FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NEUPRO (rotigotine) filed by UCB, Inc., indicating a regulatory expansion to the product’s label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Neupro (rotigotine)

Snippet

SUPPL AP for NEUPRO (ROTIGOTINE)